Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)

Q: What does CUSIP 92337R101 represent in this 13F holders report?

CUSIP 92337R101 is the security identifier for VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in Q4 2025?

213 institutional investors reported VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 92337R101

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Class A Common Stock, par value $0.001 per share
Shares outstanding: 72,325,000
Total 13F shares: 74,007,590
Share change: +8,497,924
Total reported value: $3,747,901,575
Put/Call ratio: 26%
Price per share: $50.64
Number of holders: 213
Value change: +$504,714,925
Number of buys: 134
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 92337R101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13D/G 13F	T. Rowe Price Associates, Inc. · Company	7.7%	5,461,988	$276,595,072	+$90,918,550	31 Dec 2025	13D/G 13F
VANGUARD GROUP INC	13D/G 13F	The Vanguard Group · Company	5%	3,570,401	$180,805,107	$0	31 Dec 2025	13D/G 13F
Avoro Capital Advisors LLC	13F 13D/G	Company	8.9% from 13D/G	6,210,000	$180,462,600	—	30 Sep 2025	13F 13D/G
FMR LLC	13D/G 13F	Company	4.1%	2,885,853	$146,139,596	$0	31 Dec 2025	13D/G 13F
Sofinnova Venture Partners X, L.P.	13D/G 3/4/5	Dr. Maha Katabi ("Katabi") · 10%+ Owner	4%	2,847,837	$128,465,927	$0	10 Dec 2025	13D/G 3/4/5
BlackRock, Inc.	13F	Company	5.9%	4,247,190	$123,423,343	—	30 Sep 2025	13F
Kynam Capital Management, LP	13F 13D/G	Company	5.4% from 13D/G	4,027,800	$117,047,868	—	30 Sep 2025	13F 13D/G
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5%	3,641,157	$105,812,022	—	30 Sep 2025	13F
Patrick G. Enright	3/4/5	Director	— mixed-class rows	3,616,475 mixed-class rows	$102,609,021	+$5,527,296	11 Dec 2025	3/4/5
Eversept Partners, LP	13F	Company	3.9%	2,807,836	$81,595,714	—	30 Sep 2025	13F
Sofinnova Investments, Inc.	13F	Company	3.9%	2,793,987	$81,193,262	—	30 Sep 2025	13F
Commodore Capital LP	3/4/5	10%+ Owner	— class O/S missing	4,400,000	$79,200,000	—	10 Jan 2024	3/4/5
James E. Flynn	13D/G	Deerfield Mgmt, L.P.	5.2%	3,348,117	$75,299,151	$0	06 Jun 2025	13D/G
STATE STREET CORP	13F	Company	3.2%	2,333,583	$67,813,922	—	30 Sep 2025	13F
Emster Kurt von	3/4/5	Director	— mixed-class rows	2,987,984 mixed-class rows	$53,605,062	—	17 May 2021	3/4/5
Abingworth LLP	3/4/5	10%+ Owner	— mixed-class rows	2,970,156 mixed-class rows	$53,284,158	—	13 May 2021	3/4/5
Carlyle Group Inc.	3/4/5	10%+ Owner	— class O/S missing	2,960,231	$53,284,158	—	17 Aug 2022	3/4/5
Integral Health Asset Management, LLC	13F	Company	2.4%	1,700,000	$49,402,000	—	30 Sep 2025	13F
CITADEL ADVISORS LLC	13F	Company	2.2%	1,615,338	$46,941,722	—	30 Sep 2025	13F
Pictet Asset Management Holding SA	13F	Company	2%	1,439,121	$41,820,856	—	30 Sep 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.9%	1,350,000	$39,231,000	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.8%	1,321,575	$38,410,686	—	30 Sep 2025	13F
Point72 Asset Management, L.P.	13F	Company	1.8%	1,272,027	$36,965,112	—	30 Sep 2025	13F
Tri Locum Partners LP	13F	Company	1.6%	1,190,207	$34,587,415	—	30 Sep 2025	13F
Longitude Capital Partners IV, LLC	3/4/5	10%+ Owner	— class O/S missing	1,714,285	$30,857,130	—	06 Feb 2023	3/4/5
Longitude Prime Partners, LLC	3/4/5	10%+ Owner	— class O/S missing	1,714,285	$30,857,130	—	06 Feb 2023	3/4/5
Vestal Point Capital, LP	13F	Company	1.1%	760,000	$22,085,600	—	30 Sep 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	758,566	$22,043,928	—	30 Sep 2025	13F
Woodline Partners LP	13F	Company	1%	737,578	$21,434,017	—	30 Sep 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.98%	708,423	$20,586,824	—	30 Sep 2025	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.94%	679,992	$19,651,769	—	30 Sep 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.88%	633,820	$18,418,809	—	30 Sep 2025	13F
Rock Springs Capital Management LP	13F	Company	0.85%	617,396	$17,941,528	—	30 Sep 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.83%	598,454	$17,391,073	—	30 Sep 2025	13F
MPM BioImpact LLC	13F	Company	0.78%	563,075	$16,362,960	—	30 Sep 2025	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.74%	536,000	$15,576,160	—	30 Sep 2025	13F
PFM Health Sciences, LP	13F	Company	0.71%	513,685	$14,927,686	—	30 Sep 2025	13F
First Light Asset Management, LLC	13F	Company	0.7%	507,097	$14,736,239	—	30 Sep 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.68%	490,472	$14,253,117	—	30 Sep 2025	13F
BRAIDWELL LP	13F	Company	0.65%	472,739	$13,737,795	—	30 Sep 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.64%	465,809	$13,536,410	—	30 Sep 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.64%	461,410	$13,408,575	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.64%	461,260	$13,404,217	—	30 Sep 2025	13F
Capricorn Fund Managers Ltd	13F	Company	0.62%	450,700	$13,097,342	—	30 Sep 2025	13F
Hudson Bay Capital Management LP	13F	Company	0.61%	440,591	$12,803,574	—	30 Sep 2025	13F
S.c.a. Candriam	13F	Individual	0.59%	427,189	$12,414,112	—	30 Sep 2025	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.58%	416,376	$12,099,886	—	30 Sep 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.5%	360,332	$10,471,249	—	30 Sep 2025	13F
First Turn Management, LLC	13F	Company	0.49%	354,529	$10,302,613	—	30 Sep 2025	13F
Nuveen, LLC	13F	Company	0.44%	317,679	$9,231,751	—	30 Sep 2025	13F

Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q4 2025

As of 31 Dec 2025, Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by 213 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,007,590 shares. The largest 10 holders included Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P., VANGUARD GROUP INC, Kynam Capital Management, LP, Eversept Partners, LP, FMR LLC, Deep Track Capital, LP, and Sofinnova Investments, Inc.. This page lists 213 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

173

Q4 2025 holders

213

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.